Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX to prevent postoperative pancreatic fistula after distal pancreatectomy
2024-517267-23-00Phase 2Completed
- Sponsor
- Erasmus MC
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in pancreatic fistula (POPF), sponsored by Erasmus MC. Primary endpoint: Feasibility and safety of preoperative endoscopic BOTOX injection in the sphincter of Oddi. Started Sep 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on 2024-517267-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517267-23-00.